Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?
Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next? |
|
https://doi.org/10.18632/oncotarget.26970
Pavlos Msaouel,
Alessandro Carugo,
and Giannicola Genovese
|
| 3979-3981 |
The non-random landscape of somatically-acquired uniparental disomy in cancer
The non-random landscape of somatically-acquired uniparental disomy in cancer |
|
https://doi.org/10.18632/oncotarget.26987
Pau Erola,
Keyvan Torabi,
Rosa Miró,
and Jordi Camps
|
| 3982-3984 |
Cancer vaccines: what’s next?
Cancer vaccines: what’s next? |
|
https://doi.org/10.18632/oncotarget.27006
Stéphane Depil,
Paola Bonaventura,
and Vincent Alcazer
|
| 3985-3987 |
VEGF-C as a putative therapeutic target in cancer
VEGF-C as a putative therapeutic target in cancer |
|
https://doi.org/10.18632/oncotarget.27007
Signe R. Michaelsen,
Hans S. Poulsen,
and Petra Hamerlik
|
| 3988-3990 |
Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment
Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment |
|
https://doi.org/10.18632/oncotarget.27013
Stefano A. Pileri,
Maria Carmela Vegliante,
and Sabino Ciavarella
|
| 3991-3993 |
Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism?
Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism? |
|
https://doi.org/10.18632/oncotarget.27015
Andreas Stadlbauer,
Michael Buchfelder,
Arnd Dörfler,
and Stefan Oberndorfer
|
| 3994-3995 |
Mesothelioma: Hippo pathway as a target, lessons from COMMAND
Mesothelioma: Hippo pathway as a target, lessons from COMMAND |
|
https://doi.org/10.18632/oncotarget.27018
Dean A. Fennell,
and Essa Y. Baitei
|
| 3996-3997 |
From rare to well-done: importance of rare tumors in cancer therapeutic advances
From rare to well-done: importance of rare tumors in cancer therapeutic advances |
|
https://doi.org/10.18632/oncotarget.27020
Florence Duffaud,
Sophie Piperno-Neumann,
Nicolas Penel,
and Jean-Yves Blay
|
| 3998-3999 |
An emerging role of CD9 in stemness and chemoresistance
An emerging role of CD9 in stemness and chemoresistance |
|
https://doi.org/10.18632/oncotarget.27021
Mujib Ullah,
Asma Akbar,
and Avnesh S. Thakor
|
| 4000-4001 |
Targeted therapy in CLL: changing the treatment paradigm
Targeted therapy in CLL: changing the treatment paradigm |
|
https://doi.org/10.18632/oncotarget.26964
Christof Schneider,
Daniela Steinbrecher,
and Stephan Stilgenbauer
|
| 4002-4003 |
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26958
Mavee Witherspoon,
Davinder Sandu,
Changyuan Lu,
Kehui Wang,
Robert Edwards,
Anthony Yeung,
Ozkan Gelincik,
Giovanni Manfredi,
Steven Gross,
Levy Kopelovich,
and Steven Lipkin
|
| 4004-4017 |
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26998
Celina Ang,
Samuel J. Klempner,
Siraj M. Ali,
Russell Madison,
Jeffrey S. Ross,
Eric A. Severson,
David Fabrizio,
Aaron Goodman,
Razelle Kurzrock,
James Suh,
and Sherri Z. Millis
|
| 4018-4025 |
Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool
Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool |
|
https://doi.org/10.18632/oncotarget.26999
Ali Sakhdari,
Parnian Ahmadi Moghaddam,
Chi Young Ok,
Otto Walter,
Keith Tomaszewicz,
Mandi-Lee Caporelli,
Xiuling Meng,
Jennifer LaFemina,
Giles Whalen,
Edward Belkin,
Jaroslav Zivny,
Wahid Wassef,
Bruce A. Woda,
Lloyd M. Hutchinson,
and Ediz F. Cosar
|
| 4026-4037 |
Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications
Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications |
|
https://doi.org/10.18632/oncotarget.27005
Maria-Magdalena Georgescu,
Yan Li,
Mohammad Zahidul Islam,
Christina Notarianni,
Hai Sun,
Adriana Olar,
and Gregory N. Fuller
|
| 4038-4052 |
Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma
Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27017
Osamu Ichiyanagi,
Hiromi Ito,
Sei Naito,
Takanobu Kabasawa,
Hidenori Kanno,
Takafumi Narisawa,
Masaki Ushijima,
Yuta Kurota,
Michinobu Ozawa,
Toshihiko Sakurai,
Hayato Nishida,
Tomoyuki Kato,
Mitsunori Yamakawa,
and Norihiko Tsuchiya
|
| 4053-4068 |
Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.23861
Yongshun Chen,
Xiaoyuan Wu,
Daxuan Hao,
Xinyu Cheng,
Lei Zhang,
Yougai Zhang,
Shaobo Ke,
Wei Shi,
and Chunyu He
|
| 4069-4078 |
Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes
Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes |
|
https://doi.org/10.18632/oncotarget.27035
Junjie Gao,
Tak Sum Cheng,
An Qin,
Nathan J. Pavlos,
Tao Wang,
Kai Song,
Yan Wang,
Lianzhi Chen,
Lin Zhou,
Qing Jiang,
Hiroshi Takayanagi,
Sheng Yan,
and Minghao Zheng
|
| 4079-4079 |
